表紙
市場調查報告書

乳房重建術的全球市場:2020年∼2024年

Breast Reconstruction Market by Product and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 922994
出版日期 內容資訊 英文 132 Pages
訂單完成後即時交付
價格
Back to Top
乳房重建術的全球市場:2020年∼2024年 Breast Reconstruction Market by Product and Geography - Forecast and Analysis 2020-2024
出版日期: 2020年01月21日內容資訊: 英文 132 Pages
簡介

全球乳房重建術市場在2019年∼2024年的預測期間內,預計將以約9%的年複合成長率增長,達到10億1,000萬美元的規模。乳腺癌發病率的上升推動了市場的發展。此外,強大的研究經費有望推動市場增長。

本報告提供全球乳房重建術市場相關調查分析,提供市場規模及成長率,市場趨勢,推動市場要素,課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 序文
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析
  • 價值鏈分析

第4章 市場規模

  • 市場定義
  • 2019年的市場規模
  • 市場規模與2019-2024預測
  • 市場預測

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 對手的威脅
  • 市場情況

第6章 客戶形勢

第7章 市場區隔:各產品

  • 市場區隔:各產品
  • 比較:各產品
  • 豐胸手術-市場規模與2019-2024預測
  • 組織擴張器-市場規模與預測2019年-2024
  • 市場機會:各產品

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美-市場規模與2019-2024預測
  • 歐洲-市場規模與2019-2024預測
  • 亞洲-市場規模與2019-2024預測
  • 其他地區-市場規模與2019-2024預測
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 強大的研究經費
  • 宣導活動的增加
  • DBT越來越受歡迎

第12章 業者情勢

  • 概要
  • 形勢的創新
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Allergan Plc
  • CEREPLAS
  • Establishment Labs Holdings Inc.
  • GC Aesthetics Inc.
  • Groupe SEBBIN SAS
  • Ideal Implant Inc.
  • Johnson & Johnson
  • Laboratories Arion
  • POLYTECH Health & Aesthetics GmbH
  • Sientra Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR40321

Technavio has been monitoring the global breast reconstruction market and it is poised to grow by USD 1.01 billion during 2020-2024, progressing at a CAGR of almost 9% during the forecast period. Our reports on breast reconstruction market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by Rising incidence of breast cancer. In addition, strong research funding is anticipated to boost the growth of the breast reconstruction market as well.

Market Segmentation

Technavio's global breast reconstruction market is segmented as below:

Product

  • Breast Implants
  • Tissue Expanders

Geographic segmentation

  • Asia
  • Europe
  • North America
  • ROW

Key Trends for breast reconstruction market growth

This study identifies strong research funding as the prime reasons driving the breast reconstruction market growth during the next few years.

Prominent vendors in breast reconstruction market

We provide a detailed analysis of around 25 vendors operating in the breast reconstruction market, including some of the vendors such as Allergan Plc, CEREPLAS, Establishment Labs Holdings Inc., GC Aesthetics Inc., Groupe SEBBIN SAS, Ideal Implant Inc., Johnson & Johnson, Laboratories Arion, POLYTECH Health & Aesthetics GmbH and Sientra Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value Chain Analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: CUSTOMER LANDSCAPE

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Breast implants - Market size and forecast 2019-2024
  • Tissue expanders - Market size and forecast 2019-2024
  • Market opportunity by product

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Strong research funding
  • Increasing number of awareness campaigns
  • Growing popularity of DBT

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Allergan Plc
  • CEREPLAS
  • Establishment Labs Holdings Inc.
  • GC Aesthetics Inc.
  • Groupe SEBBIN SAS
  • Ideal Implant Inc.
  • Johnson & Johnson
  • Laboratories Arion
  • POLYTECH Health & Aesthetics GmbH
  • Sientra Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

  • Exhibit 01: Global healthcare supplies market
  • Exhibit 02: Segments of global healthcare supplies market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendors: Key offerings
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Customer landscape
  • Exhibit 19: Product - Market share 2019-2024 (%)
  • Exhibit 20: Comparison by product
  • Exhibit 21: Breast implants - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 22: Breast implants - Year-over-year growth 2020-2024 (%)
  • Exhibit 23: Tissue expanders - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 24: Tissue expanders - Year-over-year growth 2020-2024 (%)
  • Exhibit 25: Market opportunity by product
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Estimated breast cancer rates in 2018
  • Exhibit 39: Cosmetic surgical procedures
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Organizations conducting awareness campaigns
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Allergan Plc - Vendor overview
  • Exhibit 48: Allergan Plc - Business segments
  • Exhibit 49: Allergan Plc - Organizational developments
  • Exhibit 50: Allergan Plc - Segment focus
  • Exhibit 51: Allergan Plc - Key offerings
  • Exhibit 52: CEREPLAS - Vendor overview
  • Exhibit 53: CEREPLAS - Product segments
  • Exhibit 54: CEREPLAS - Key offerings
  • Exhibit 55: Establishment Labs Holdings Inc. - Vendor overview
  • Exhibit 56: Establishment Labs Holdings Inc. - Business segments
  • Exhibit 57: Establishment Labs Holdings Inc. - Organizational developments
  • Exhibit 58: Establishment Labs Holdings Inc. - Key offerings
  • Exhibit 59: GC Aesthetics Inc. - Vendor overview
  • Exhibit 60: GC Aesthetics Inc. - Product segments
  • Exhibit 61: GC Aesthetics Inc. - Organizational developments
  • Exhibit 62: GC Aesthetics Inc. - Key offerings
  • Exhibit 63: Groupe SEBBIN SAS - Vendor overview
  • Exhibit 64: Groupe SEBBIN SAS - Product segments
  • Exhibit 65: Groupe SEBBIN SAS - Key offerings
  • Exhibit 66: Ideal Implant Inc. - Vendor overview
  • Exhibit 67: Ideal Implant Inc. - Key offerings
  • Exhibit 68: Johnson & Johnson - Vendor overview
  • Exhibit 69: Johnson & Johnson - Business segments
  • Exhibit 70: Johnson & Johnson - Organizational developments
  • Exhibit 71: Johnson & Johnson - Geographic focus
  • Exhibit 72: Johnson & Johnson - Segment focus
  • Exhibit 73: Johnson & Johnson - Key offerings
  • Exhibit 74: Laboratories Arion - Vendor overview
  • Exhibit 75: Laboratories Arion - Key offerings
  • Exhibit 76: POLYTECH Health & Aesthetics GmbH - Vendor overview
  • Exhibit 77: POLYTECH Health & Aesthetics GmbH - Product segments
  • Exhibit 78: POLYTECH Health & Aesthetics GmbH - Key offerings
  • Exhibit 79: Sientra Inc. - Vendor overview
  • Exhibit 80: Sientra Inc. - Business segments
  • Exhibit 81: Sientra Inc. - Organizational developments
  • Exhibit 82: Sientra Inc. - Geographic focus
  • Exhibit 83: Sientra Inc. - Segment focus
  • Exhibit 84: Sientra Inc. - Key offerings
  • Exhibit 85: Validation techniques employed for market sizing
  • Exhibit 86: Definition of market positioning of vendors
Back to Top